Skip to Content

About Us

Research Tools

For more information on UTMDACC technologies, please contact the Office of Technology Commercialization (713-745-9604).  Please indicate the technology number (MDA#) in your correspondence.


MDA10-110
Generation of Bi-paternal Progeny
Please contact the office for more information on this technology.


MDA10-095
Monoclonal Antibodies anti-BDCA2
Please contact the office for more information on this technology.


MDA10-076
MDA-IBC3
Please contact the office for more information on this technology.


MDA10-075
PKM2 Monoclonal Antibodies
Please contact the office for more information on this technology.


MDA10-056
Tox-4 Monoclonal Antibody and Tox-4 Knockout Mouse
Please contact the office for more information on this technology.


MDA10-040
KrasLA1/+;p53R172HdeltaG/+ Mouse
Please contact the office for more information on this technology.


MDA10-023
SIN1 Deficient Embryonic Fibroblast Cell Lines
Please contact the office for more information on this technology.


MDA09-102
Antibody to HAF (SART1)
Please contact the office for more information on this technology.


MDA09-073
Hairless SKHIN Inbred Strain
Please contact the office for more information on this technology.


MDA09-061
Rat Monoclonal Antibodies Against Mouse IL-22
Please contact the office for more information on this technology.


MDA09-060
RPPA Data
Please contact the office for more information on this technology.


MDA09-032
Digital Restriction Enzyme Analysis of Methylation (DREAM)
WO2010/085774


MDA09-031
Dose-response Linearizer of Gene Expression
Please contact the office for more information on this technology.


MDA09-020
Hybridoma Clone for 1A3 Anti-Alix Monoclonal Antibody
Please contact the office for more information on this technology.


MDA09-008
Reverse Phase Protein Arrays (RPPA) of Cell Lines
Please contact the office for more information on this technology.


MDA09-003
Human Mid-Gut Carcinoid Tumor Cell Line-CNDT10.5
Please contact the office for more information on this technology.


MDA09-002
Anti-SIN1 polyclonal antibody
Please contact the office for more information on this technology.


MDA08-152
IL-17F-RFP Reporter/IL-17F-Deficient Mice
Please contact the office for more information on this technology.


MDA08-151
Generation of IL-17 Deficient Mice
Please contact the office for more information on this technology.


MDA08-148
Cell-based Assay to Measure mRNA Translation
Please contact the office for more information on this technology.


MDA08-145
Epithelial-mesenchymal Transition (EMT) Reporter Cell Line
Please contact the office for more information on this technology.


MDA08-134
Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-Like Changes in the Mouse: A New, Convenient, Animal Model for the Study of Smoke-Induced Human Emphysema
Please contact the office for more information on this technology.


MDA08-133
Rabbit Polyclonal Antibody Against Mouse IL-17F
Please contact the office for more information on this technology.


MDA08-121
Immortalized Human Pancreatic Stellate Cells
Please contact the office for more information on this technology.


MDA08-115
Rat Anti-mouse BTNL2 Monoclonal Antibodies, Clone F7
Please contact the office for more information on this technology.


MDA08-108
Anti-IL-25 Monoclonal Antibody
Please contact the office for more information on this technology.


MDA08-094
Anti-human Thymic Stromal Lymphopoietin Receptor (TSLPR) Antibodies
Please contact the office for more information on this technology.


MDA08-066
MDA-IBC-1
Please contact the office for more information on this technology.


MDA08-058
1483 Cell Line
Please contact the office for more information on this technology.


MDA08-053
A Novel Transgenic Murine Model of Obesity: Autotaxin Transgenic Mouse
Please contact the office for more information on this technology.


MDA08-050
Tamoxifen Resistant MCF7 Breast Cancer Line Genetically Modified to Express the Gene CtIP (RBBP8) Under the Control of the Tet-off System
Please contact the office for more information on this technology.


MDA08-019
Active Trypsin
Please contact the office for more information on this technology.


MDA08-012
Methods For Detecting Molecule-Molecule Interactions With A Single Detection Channel
WO/2009/100442


MDA08-006
Method to Expand Antigen-Specific T Cells
Please contact the office for more information on this technology.


MDA08-001
Regulation of Post-Prandial Glucose by F-BAR Proteins
Please contact the office for more information on this technology.


MDA07-122
Highly Metastatic Murine Pancreatic Cancer Cell Line, Panc02-H7
Please contact the office for more information on this technology.


MDA07-121
Gioblastoma Stem-like Cells
Please contact the office for more information on this technology.


MDA07-120
Gcn5 hat/hat mouse
Please contact the office for more information on this technology.


MDA07-092
MTA1-dependent Mouse Models of Human Diseases
Please contact the office for more information on this technology.


MDA07-088
Matrix Gla Protein-Deficient Mice
Please contact the office for more information on this technology.


MDA07-076
Hybridoma Clone for 2F3 anti-xCdc25C Monoclonal Antibody
Please contact the office for more information on this technology.


MDA07-075
Hybridoma Clone for 3D5 Anti-xp42-MAPK Antibody
Please contact the office for more information on this technology.


MDA07-065
Aminopeptidase N-null Mice
Please contact the office for more information on this technology.


MDA06-139
Anti-Human Thymic Stromal Lymphopoietin (TSLP) Antibodies
Please contact the office for more information on this technology.


MDA06-138
Anti Human-OX40L Antibody
Please contact the office for more information on this technology.


MDA06-131
Anti Human-ILT7 Monoclonal Antibody
Please contact the office for more information on this technology.


MDA06-121
A Series of Cell Lines that can be Used to Screen for Factors (Drugs, Molecules, Natural Substances) that Reverse Gene Silencing by DNA Methylation and Histone Deacetylation
Please contact the office for more information on this technology.


MDA06-111
TAP-p53 Mouse and ES Cell Lines
Please contact the office for more information on this technology.


MDA06-108
Anti-DSP Monoclonal Antibody, 2G7.3
Please contact the office for more information on this technology.


MDA06-092
High-Throughput Screening for Inhibitors of Protein-Protein Interactions
Please contact the office for more information on this technology.


MDA06-083
Method of Identifying an Agent that Promotes Generation of New Cardiomyocytes
Please contact the office for more information on this technology.


MDA06-071
Human Pancreatic Cancer Cell Lines L3.6 sl and L3.6 pl
Please contact the office for more information on this technology.


MDA06-062
Anti-Alix Antibodies and Hybridomas
WO2008/019291


MDA06-044
The Novel Transgenic Mouse Models of Human Breast Cancer
Please contact the office for more information on this technology.


MDA06-030
Tissue-Specific Knock Down of Gene of Interest by Using Novel siRNA/miRNA Approach
Please contact the office for more information on this technology.


MDA06-026
A2L2 Mammary Tumor Cell Line
Please contact the office for more information on this technology.


MDA06-014
EWS-FL11 Transgenic Mouse (Lines A, B and C)
Please contact the office for more information on this technology.


MDA06-001
CARM1 Knockout Cell Lines
Please contact the office for more information on this technology.


MDA05-074
Development of a Novel Autophagy Detection System for Cultured Cells and Clinical Specimens: A Polyclonal Antibody for Human Microtubule-Associated Protein 1 Light Chain 3 Isoform B (LC3B)
Please contact the office for more information on this technology.


MDA05-049
Metastatic Prostate Cancer Cell Line
Please contact the office for more information on this technology.


MDA04-092
TCL1 Monoclonal Antibody
Please contact the office for more information on this technology.


MDA04-087
Development of LEKTI Monoclonal Antibody
Please contact the office for more information on this technology.


MDA04-086
Rapid Detection of IgH/BCL2 Rearrangement in Follicular Lymphoma by Interphase Fluorescence In Situ Hybridization with Bacterial Artificial Chromosome Probes
Please contact the office for more information on this technology.


MDA04-001
Antibody Specific for Histone Acetylated at Lysines 9 and/or 18
Please contact the office for more information on this technology.


MDA03-104
A Mouse Model for Human Scleroderma and Fibrotic Diseases
Please contact the office for more information on this technology.


MDA03-050
Coculture of Prostate Cancer Cells and Osteblasts
Please contact the office for more information on this technology.


MDA03-017
Site-specific Bcr Antibody
Please contact the office for more information on this technology.


MDA02-080
Breast Cancer Serial Analysis of Gene Expression (SAGE) Data Libraries
Please contact the office for more information on this technology.


MDA02-072
RAIN Protein and DNAs and Uses Therein
US-2004-0086848-A1
WO2004/011620


MDA02-051
Col2a1-Directed Expression of Cre Recombinase in Differentiating Chondrocytes in Transgenic Mice
Please contact the office for more information on this technology.


MDA02-040
Osteocalcin Promoter Plasmid
Please contact the office for more information on this technology.


MDA02-039
Generation of a Transgenic Mouse in which a Transcriptional Enhancer in the Mouse ProAlpha2(1) Collagen Gene Controls Expression of a Reporter Specifically in Fibroblastic Cells
Please contact the office for more information on this technology.


MDA02-007
Adenoviral Vectors Expressing the Bax Gene from Tumor- or Cell-Type Specific Promoter and Methods of Use Thereof
Please contact the office for more information on this technology.


MDA01-076
Transcriptome Analysis of the Developing Mouse Retina
Please contact the office for more information on this technology.


MDA01-044
Establishment of Various Metastatic Carcinoma Cell Lines
Please contact the office for more information on this technology.


MDA01-022
IGF-1 Transgenic Mouse
Please contact the office for more information on this technology.


MDA00-070
Medical Utility of Sequence Specific Phosphotyrosine Antibodies for Monitoring Therapy in Philadelphia Chromosome Positive Leukemia Patients
Please contact the office for more information on this technology.


MDA00-055
Feed-Based Treatment for Internal and External Parasitic Agents in Laboratory Rodents
Please contact the office for more information on this technology.


MDA99-066
Development of an Animal Model for Disseminated Human Lung Tumors
Please contact the office for more information on this technology.


MDA99-052
Adenoviral IkBalpha Mutant
Please contact the office for more information on this technology.


MDA99-035
GST-Xp95N
Please contact the office for more information on this technology.


MDA99-034
Development of Monoclonal Antibody Against DMBT1 Recombinant Protein
Please contact the office for more information on this technology.


MDA98-023
Mouse Model of Inducible and Reversible Osteoporosis
Please contact the office for more information on this technology.


MDA98-009
(Eker Rat Model) An In Vivo Model System for Evaluating Therapeutic Approaches for Uterine Leiomyoma
Please contact the office for more information on this technology.


MDA97-043
Establishment of Human Breast Carcinoma Cell Lines
Please contact the office for more information on this technology.


MDA97-007
Human Prostate Cancer Cell Lines MDA Pca 2a and MDA Pca 2b
Please contact the office for more information on this technology.


MDA96-038
Monoclonal Antibody Which Recognizes a Well-Defined Sequence
Please contact the office for more information on this technology.


MDA95-059
The sm22a Gene Control Region as a Smooth Muscle Cell-Specific Regulatory Cassette for Gene Therapy
5,837,534
6,015,711


MDA95-014
Identification of a Human Tumor Suppressor Gene
Please contact the office for more information on this technology.


MDA94-047
Androgen-Independent and Metastatic Human Prostrate Cancer Cell Sublines Derived from Parental Androgen-Dependent LNCaP Cells
Please contact the office for more information on this technology.


MDA94-044
(ELT cell lines) An In Vitro/In Vivo Model System for Evaluating and Characterizing Therapeutic Agents for Uterine Leiomyomata
Please contact the office for more information on this technology.


MDA94-028
MPM2 - A Monoclonal Antibody Preferentially Recognizing Miotic Cells of a Variety of Species
Please contact the office for more information on this technology.


MDA92-010
p53 Plasmids
Please contact the office for more information on this technology.

For More Information


© 2014 The University of Texas MD Anderson Cancer Center